For decades, Indian hospitals imported sutures from Ethicon (US) or B. Braun (Germany). Now, local companies like Sutures India, DemeTECH, and Meril are making high‑quality sutures at 40‑50% lower cost. The India surgical sutures market research study shows that domestic manufacturers hold over 30% of the market and are growing faster than MNCs, driven by the Make in India initiative and government procurement policies.

What's the quality like? Good — many Indian sutures are CE‑marked and FDA‑approved. They use the same materials (polyglactin, polypropylene) and undergo similar sterility testing. The India surgical sutures market analysis notes that the main differentiator is brand trust — surgeons who trained on Ethicon are slow to switch.

But price pressure is real. The government's Jan Aushadhi scheme sells generic sutures at a fraction of the cost, forcing all players to compete on value.

The message: if you're a hospital procurement manager, consider local brands. They're safe, effective, and save money. And if you're a surgeon, give them a trial — you might be pleasantly surprised.